- Wednesday, April 15, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Next Generation Biomanufacturing Market- By Work flow and Product (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing), By Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global Next-Generation Biomanufacturing Market Overview
The global next-generation biomanufacturing market is estimated to reach USD 43.3 billion by 2030, growing at a CAGR of 9.4% during the forecast period of 2022-2030. It was valued at USD 22.25 billion in 2022. Biomanufacturing refers to biotechnology that uses a biological system to produce biomaterial and biochemicals and use them in industrial application, food and beverage processing, and manufacturing using genetic engineering techniques. The next-generation biomanufacturing will be cost-effective as it incorporates various innovative technologies in a single facility in half the construction time and operating cost of medicines. The plant will have portable equipment and disposable components, which provides better agility and flexibility and speed in manufacturing.Global Next-Generation Biomanufacturing Market Insights
owing to rising technology in biomanufacturing products, increased funding by private investors and government, increasing environmental concerns, and the emerging need for seamless service in manufacturing. Next-generation biomanufacturing will fuel the market demand for various industries like food and beverages, pharmaceuticals, and other industrial applications. Due to the rising need for utilization, the resources, improve waste management, cost-efficiency, and improves flexibility and speed of the medicines manufacturing leads to market growth. Moreover, various start-ups with technical expertise are investing in next-generation biomanufacturing to overcome the shortcomings of existing biomanufacturing. Thus, promote the comprehensive upgrading of biomanufacturing and solve the ecological, resource, and sustainable development crisis. Additionally, With the rapid development of molecular biology, biochemistry, and synthetic biology, industrial biotechnology that uses biological products such as living organisms, organelles, or enzymes to process raw materials in the form of biochemical reactions is considered to be a more effective means. Furthermore, the rising adoption of single-use products, such as single-use bio-containers, and bioreactors have enhanced the market trends of the next-generation biomanufacturing market. As it promotes the green and clean environment, reduces contamination of the product, minimizes wastage and cost as well.Growth Driver
Seamless service
The next-generation biomanufacturing market will help to promote the seamless service, which enhances both the quality and efficiency of the product. Compared to the present generation biomanufacturing, next-generation manufacturing will fuel its market owing to the use of disposable products in the manufacturing plant to reduce waste and promote environmental benefits.Technology advancement
The technology advancement in biomanufacturing has the medicines quality and efficiency and reduce the construction time. The water and energy level have also reduced, which promotes low-level carbon emissions. Various technology advance manufacturing companies are using tools that help in understanding human biology and thus use human genetics tools to reduce the complexities of diseases.By Workflow and product Segmental Analysis
Based on the workflow and product, the global next-generation biomanufacturing market segmented into Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing. Single-use upstream manufacturing has captured the largest segment in the global next-generation biomanufacturing market. Single-use upstream is further classified into Single-Use Bioreactors, Single-Use Bags and Containers, Single-Use Tubing and Connectors, Single-Use Mixing Systems, Single-Use Sensors, and Probes. The single-use bioreactors, bags, container, and other tools used in the manufacturing process as it helps in easy disposal, reduce the risk of contamination. It also reduces the cost associated with the sterilization, cleaning of the equipment and also optimizes the energy and minimizes the use of water. Therefore, the demand for next-generation biomanufacturing will capture the largest market share in the future.By Application Segmental Analysis
Based on the Application, the global next-generation biomanufacturing market classified into Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, and Others. Recombinant proteins held the largest market share in the global next-generation biomanufacturing market—the recombinant proteins produced by applying recombinant DNA or recombinant RNA technology. The production of recombinant proteins in vitro mainly includes four significant systems: prokaryotic protein expression, mammalian cell protein expression, yeast protein expression, and insect cell protein expression. The E. coli expression system has become the most commonly used for recombinant protein production. Due to the high level of expression, low cost, simple culture conditions, rapid manufacturing, robust scalability, easy conversion, protein expression can optimize through multiple parameters, easy to form a disulfide bond.By Region Segmental Analysis
Based on geography, the global next-generation biomanufacturing market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America will be expecting to witness the highest growth during the forecast period from 2022-2030. The rising disposable income, advancement in technology, people’s awareness of making the country pollution free and reduce carbon emission. It coupled with North America’s government initiatives in investing next-generation biomanufacturing. Thus, it will capture the most significant share the worldwide will fuel the demand for the global next-generation biomanufacturing demand.Competitor Analysis
Companies such as Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd among others are key players in the global next-generation biomanufacturing market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global next generation biomanufacturing manufacturing companies
- Research organizations and consulting companies’ next generation biomanufacturing
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 19.25 Billion |
| Revenue forecast in 2027 | USD 40.3 Billion |
| Growth Rate | CAGR of 9.4% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | Merck KGaA, Thermo Fisher Scientific Inc.,bbi-biotech GmbH, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd |
Recent Developments
- In August 2021, McMaster teamed with Sartorius Stedim Biotech to improve manufacturing processes of antibody and virus-based treatments for COVID-19, cancers, and genetic disorders.
- In August 2021, Provectus Algae announced to Expand into an additional large-scale Microalgae biomanufacturing facility.
- In September 2021, NTX and the University of Notre Dame collaborated with a jointly developed algorithm called DruID to identify and evaluate the drug potential of previously described natural products.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Work flow and Product- Continuous Upstream Biomanufacturing
- Bioreactors/Fermenters
- Cell Culture Products
- Filtration Systems
- Bags & Containers
- Mixing System
- Sterilizers
- Biosafety Cabinets
- Incubators
- Others
- Single-Use Upstream Biomanufacturing
- Single-Use Bioreactors
- Single-Use Bags and Containers
- Single-Use Tubing and Connectors
- Single-Use Mixing Systems
- Single-Use Sensors and Probes
- Downstream Biomanufacturing
- Chromatography Systems
- Filtration Systems
- Membrane Absorbers
- Instruments and Accessories
- Single-Use Equipment and Accessories
- Monoclonal Antibodies
- Hormones
- Vaccines
- Recombinant Proteins
- Others
- Commercial Stage
- Preclinical and Development Stage
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Sustainable Plastic Packaging Market
Clinical Decision Support System Market
APAC Gas Chromatography Market
Remote Patient Monitoring Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Next Generation Biomanufacturing Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Work Flow and Product
5.2.1.1. Continuous Upstream Biomanufacturing
5.2.1.1.1. Bioreactors/Fermenters
5.2.1.1.2. Cell Culture Products
5.2.1.1.3. Filtration Systems
5.2.1.1.4. Bags & Containers
5.2.1.1.5. Mixing System
5.2.1.1.6. Sterilizers
5.2.1.1.7. Biosafety Cabinets
5.2.1.1.8. Incubators
5.2.1.1.9. Others
5.2.1.2. Single-Use Upstream Biomanufacturing
5.2.1.2.1. Single-Use Bioreactors
5.2.1.2.2. Single-Use Bags and Containers
5.2.1.2.3. Single-Use Tubing and Connectors
5.2.1.2.4. Single-Use Mixing Systems
5.2.1.2.5. Single-Use Sensors and Probes
5.2.1.3. Downstream Biomanufacturing
5.2.1.3.1. Chromatography Systems
5.2.1.3.2. Filtration Systems
5.2.1.3.3. Membrane Absorbers
5.2.1.3.4. Instruments and Accessories
5.2.1.3.5. Single-Use Equipment and Accessories
5.2.1. By Medical Application
5.2.1.2. Monoclonal Antibodies
5.2.1.3. Hormones
5.2.1.4. Vaccines
5.2.1.5. Recombinant Proteins
5.2.1.6. Others
5.2.2. By End-User
5.2.2.2. Commercial Stage
5.2.2.3. Preclinical and Development Stage
5.2.3. By Region
5.2.3.2. North America
5.2.3.3. Europe
5.2.3.4. Asia-Pacific
5.2.3.5. South America
5.2.3.6. The Middle East & Africa
- North America Next Generation Biomanufacturing Market Overview
6.2. North America Next Generation Biomanufacturing Market Size & Forecast,2017-2030
6.2.1. Demand
6.2.1.2. By Value (USD Billion)
6.3. Market Share & Forecast, 2017-2030
5.2.2. By Work Flow and Product
5.2.2.1. Continuous Upstream Biomanufacturing
5.2.2.1.1. Bioreactors/Fermenters
5.2.2.1.2. Cell Culture Products
5.2.2.1.3. Filtration Systems
5.2.2.1.4. Bags & Containers
5.2.2.1.5. Mixing System
5.2.2.1.6. Sterilizers
5.2.2.1.7. Biosafety Cabinets
5.2.2.1.8. Incubators
5.2.2.1.9. Others
5.2.2.2. Single-Use Upstream Biomanufacturing
5.2.2.2.1. Single-Use Bioreactors
5.2.2.2.2. Single-Use Bags and Containers
5.2.2.2.3. Single-Use Tubing and Connectors
5.2.2.2.4. Single-Use Mixing Systems
5.2.2.2.5. Single-Use Sensors and Probes
5.2.2.3. Downstream Biomanufacturing
5.2.2.3.1. Chromatography Systems
5.2.2.3.2. Filtration Systems
5.2.2.3.3. Membrane Absorbers
5.2.2.3.4. Instruments and Accessories
5.2.2.3.5. Single-Use Equipment and Accessories
6.3.1. By Medical Application
6.3.1.2. Monoclonal Antibodies
6.3.1.3. Hormones
6.3.1.4. Vaccines
6.3.1.5. Recombinant Proteins
6.3.1.6. Others
6.3.2. By End-User
6.3.2.2. Commercial Stage
6.3.2.3. Preclinical and Development Stage
6.3.3. By Country
6.3.3.2. US
6.3.3.3. Canada
6.3.3.4. Mexico
6.3.4. Company Market Share (Top 3-5)
6.3.5. Economic Impact Study on North America Next Generation Biomanufacturing Market
- Europe Next Generation Biomanufacturing Market Overview
7.2. Europe Next Generation Biomanufacturing Market Size & Forecast,2017-2030
7.2.1. Demand
7.2.1.2. By Value (USD Billion)
7.3. Market Share & Forecast, 2017-2030
5.2.3. By Work Flow and Product
5.2.3.1. Continuous Upstream Biomanufacturing
5.2.3.1.1. Bioreactors/Fermenters
5.2.3.1.2. Cell Culture Products
5.2.3.1.3. Filtration Systems
5.2.3.1.4. Bags & Containers
5.2.3.1.5. Mixing System
5.2.3.1.6. Sterilizers
5.2.3.1.7. Biosafety Cabinets
5.2.3.1.8. Incubators
5.2.3.1.9. Others
5.2.3.2. Single-Use Upstream Biomanufacturing
5.2.3.2.1. Single-Use Bioreactors
5.2.3.2.2. Single-Use Bags and Containers
5.2.3.2.3. Single-Use Tubing and Connectors
5.2.3.2.4. Single-Use Mixing Systems
5.2.3.2.5. Single-Use Sensors and Probes
5.2.3.3. Downstream Biomanufacturing
5.2.3.3.1. Chromatography Systems
5.2.3.3.2. Filtration Systems
5.2.3.3.3. Membrane Absorbers
5.2.3.3.4. Instruments and Accessories
5.2.3.3.5. Single-Use Equipment and Accessories
7.3.1. By Medical Application
7.3.1.2. Monoclonal Antibodies
7.3.1.3. Hormones
7.3.1.4. Vaccines
7.3.1.5. Recombinant Proteins
7.3.1.6. Others
7.3.2. By End-User
7.3.2.2. Commercial Stage
7.3.2.3. Preclinical and Development Stage
7.3.3. By Country
7.3.3.2. Germany
7.3.3.3. UK
7.3.3.4. France
7.3.3.5. Italy
7.3.3.6. Rest of Europe
7.3.4. Company Market Share (Top 3-5)
7.3.5. Economic Impact Study on Europe Next Generation Biomanufacturing Market
- Asia-Pacific Next Generation Biomanufacturing Market Overview
8.2. Asia-Pacific Next Generation Biomanufacturing Market Size & Forecast,2017-2030
8.2.1. Demand
8.2.1.2. By Value (USD Billion)
8.3. Market Share & Forecast, 2017-2030
5.2.4. By Work Flow and Product
5.2.4.1. Continuous Upstream Biomanufacturing
5.2.4.1.1. Bioreactors/Fermenters
5.2.4.1.2. Cell Culture Products
5.2.4.1.3. Filtration Systems
5.2.4.1.4. Bags & Containers
5.2.4.1.5. Mixing System
5.2.4.1.6. Sterilizers
5.2.4.1.7. Biosafety Cabinets
5.2.4.1.8. Incubators
5.2.4.1.9. Others
5.2.4.2. Single-Use Upstream Biomanufacturing
5.2.4.2.1. Single-Use Bioreactors
5.2.4.2.2. Single-Use Bags and Containers
5.2.4.2.3. Single-Use Tubing and Connectors
5.2.4.2.4. Single-Use Mixing Systems
5.2.4.2.5. Single-Use Sensors and Probes
5.2.4.3. Downstream Biomanufacturing
5.2.4.3.1. Chromatography Systems
5.2.4.3.2. Filtration Systems
5.2.4.3.3. Membrane Absorbers
5.2.4.3.4. Instruments and Accessories
5.2.4.3.5. Single-Use Equipment and Accessories
8.3.1. By Medical Application
8.3.1.2. Monoclonal Antibodies
8.3.1.3. Hormones
8.3.1.4. Vaccines
8.3.1.5. Recombinant Proteins
8.3.1.6. Others
8.3.2. By End-User
8.3.2.2. Commercial Stage
8.3.2.3. Preclinical and Development Stage
8.3.3. By Country
8.3.3.2. India
8.3.3.3. Japan
8.3.3.4. Australia
8.3.3.5. Rest of Asia Pacific
8.3.4. Company Market Share (Top 3-5)
8.3.5. Economic Impact Study on Asia Pacific Next Generation Biomanufacturing Market
- South America Next Generation Biomanufacturing Market Overview
9.2. South America Next Generation Biomanufacturing Market Size & Forecast,2017-2030
9.2.1. Demand
9.2.1.2. By Value (USD Billion)
9.3. Market Share & Forecast, 2017-2030
5.2.5. By Work Flow and Product
5.2.5.1. Continuous Upstream Biomanufacturing
5.2.5.1.1. Bioreactors/Fermenters
5.2.5.1.2. Cell Culture Products
5.2.5.1.3. Filtration Systems
5.2.5.1.4. Bags & Containers
5.2.5.1.5. Mixing System
5.2.5.1.6. Sterilizers
5.2.5.1.7. Biosafety Cabinets
5.2.5.1.8. Incubators
5.2.5.1.9. Others
5.2.5.2. Single-Use Upstream Biomanufacturing
5.2.5.2.1. Single-Use Bioreactors
5.2.5.2.2. Single-Use Bags and Containers
5.2.5.2.3. Single-Use Tubing and Connectors
5.2.5.2.4. Single-Use Mixing Systems
5.2.5.2.5. Single-Use Sensors and Probes
5.2.5.3. Downstream Biomanufacturing
5.2.5.3.1. Chromatography Systems
5.2.5.3.2. Filtration Systems
5.2.5.3.3. Membrane Absorbers
5.2.5.3.4. Instruments and Accessories
5.2.5.3.5. Single-Use Equipment and Accessories
9.3.1. By Medical Application
9.3.1.2. Monoclonal Antibodies
9.3.1.3. Hormones
9.3.1.4. Vaccines
9.3.1.5. Recombinant Proteins
9.3.1.6. Others
9.3.2. By End-User
9.3.2.2. Commercial Stage
9.3.2.3. Preclinical and Development Stage
9.3.3. By Country
9.3.3.2. Brazil
9.3.3.3. Argentina
9.3.3.4. Rest of South America
9.3.4. Company Market Share (Top 3-5)
9.3.5. Economic Impact Study on South America Next Generation Biomanufacturing Market
- The Middle East & Africa Next Generation Biomanufacturing Market Overview
10.2. The Middle East & Africa Next Generation Biomanufacturing Market Size & Forecast,2017-2030
10.2.1. Demand
10.2.1.2. By Value (USD Billion)
10.3. Market Share & Forecast, 2017-2030
5.2.6. By Work Flow and Product
5.2.6.1. Continuous Upstream Biomanufacturing
5.2.6.1.1. Bioreactors/Fermenters
5.2.6.1.2. Cell Culture Products
5.2.6.1.3. Filtration Systems
5.2.6.1.4. Bags & Containers
5.2.6.1.5. Mixing System
5.2.6.1.6. Sterilizers
5.2.6.1.7. Biosafety Cabinets
5.2.6.1.8. Incubators
5.2.6.1.9. Others
5.2.6.2. Single-Use Upstream Biomanufacturing
5.2.6.2.1. Single-Use Bioreactors
5.2.6.2.2. Single-Use Bags and Containers
5.2.6.2.3. Single-Use Tubing and Connectors
5.2.6.2.4. Single-Use Mixing Systems
5.2.6.2.5. Single-Use Sensors and Probes
5.2.6.3. Downstream Biomanufacturing
5.2.6.3.1. Chromatography Systems
5.2.6.3.2. Filtration Systems
5.2.6.3.3. Membrane Absorbers
5.2.6.3.4. Instruments and Accessories
5.2.6.3.5. Single-Use Equipment and Accessories
10.3.1. By Medical Application
10.3.1.2. Monoclonal Antibodies
10.3.1.3. Hormones
10.3.1.4. Vaccines
10.3.1.5. Recombinant Proteins
10.3.1.6. Others
10.3.2. By End-User
10.3.2.2. Commercial Stage
10.3.2.3. Preclinical and Development Stage
10.3.3. By Country
10.3.3.2. Saudi Arabia
10.3.3.3. UAE
10.3.3.4. South Africa
10.3.3.5. Rest of the Middle East & Africa
10.3.4. Company Market Share (Top 3-5)
10.3.5. Economic Impact Study on Middle East & Africa Next Generation Biomanufacturing Market
- Competitor Analysis
11.2. Company Description
11.3. Financial Analysis
11.4. Key Products
11.5. Key Management Personnel
11.6. Contact Address
11.7. SWOT Analysis
11.8. Company Profile
11.8.1. Merck KGaA
11.8.2. Thermo Fisher Scientific Inc.
11.8.3. Danaher Corporation
11.8.4. Eppendorf AG
11.8.5. Sartorius AG
11.8.6. GEA Group Aktiengesellschaft
11.8.7. bbi-biotech GmbH
11.8.8. Esco Group of Companies
11.8.9. Pierre Guérin
11.8.10. Solaris Biotechnology Srl.
11.8.11. PBS Biotech, Inc.
11.8.12. ZETA GmbH
11.8.13. Applikon Biotechnology BV
11.8.14. Meissner Filtration Products, Inc.
11.8.15. Shanghai Bailun Biotechnology Co. Ltd.
11.8.16. Other Prominent Players
Frequently Asked Questions (FAQ):
Biomanufacturing produces biomaterial and biochemicals using biological systems in industrial applications, manufacturing, and food and beverage processing using genetic engineering techniques.
The global next-generation biomanufacturing market is estimated to reach USD 43.3 billion by 2030, and It was valued at USD 22.25 billion in 2022.
The growth rate of the Next Generation Biomanufacturing technology market is 9.4% during the forecast period.
Seamless service, Technological advancement are the driving forces of the Next Generation Biomanufacturing technology market.
By application, the Next Generation Biomanufacturing technology market is classified as Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others.
